These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3326580)

  • 1. Significance of anti-HTLV-III testing of volunteer blood donors.
    Grindon AJ
    Beitr Infusionther Klin Ernahr; 1987; 18():1-5. PubMed ID: 3326580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of anti-HTLV-III antibodies in volunteer blood donors in Guipuzcoa].
    Cortés A; Francisco C; Larrañaga MJ; Cárdenas JM
    Med Clin (Barc); 1987 Jan; 88(1):38-9. PubMed ID: 3644127
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of anti-HTLV III: modification of a commercial enzyme immunoassay.
    Barr A; Muir W; Dow BC; Arnott J; Macvarish IP
    Med Lab Sci; 1987 Jan; 44(1):97-9. PubMed ID: 3309535
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening blood donors for HTLV-III antibody.
    Mann DA
    JAMA; 1986 Nov; 256(17):2344-5. PubMed ID: 3534328
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibodies reacting with the antigens of the human immunodeficiency virus in systemic lupus erythematosus].
    Nasonov EL; Aleksandrova LZ; Korneeva MN; Solov'ev SK; Nosik DN
    Ter Arkh; 1987; 59(7):40-2. PubMed ID: 3499678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV antibodies: test methods in the group trial].
    Kühnl P; Seidl S
    Beitr Infusionther Klin Ernahr; 1987; 18():13-6. PubMed ID: 3326583
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HTLV III testing of blood donors and recipients, Hawaii experience.
    Frohlich J
    Hawaii Med J; 1986 Nov; 45(11):391-2. PubMed ID: 3468095
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HIV screening in Canadian blood donors.
    CMAJ; 1986 Oct; 135(8):901. PubMed ID: 3463387
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HTLV III ELISA and Western blot testing in a blood donor population: implications for donor notification.
    Kleinman S; Anton-Guirigis H; Culver BD; Taylor TH; Prince HE; Kaplan HS
    Vox Sang; 1986; 51(2):143-7. PubMed ID: 3535251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The combined immunoenzyme test: anti-HIV-1 and -2 and anti-HTLV-1 in the detection of donors with retrovirus infections].
    Dobec M; Jung M; Zupancić-Salek S; Burek V; Mihaljević I; Grgicević D
    Lijec Vjesn; 1993; 115(5-6):142-5. PubMed ID: 8302133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
    Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of anti-HTLV-III antibodies in blood donors and risk populations in Zaragoza].
    Callén L; Gutiérrez M; Lasierra P; Larrad L
    Med Clin (Barc); 1986 Jun; 87(2):82. PubMed ID: 3461230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of anti-HIV antibody by enzyme immunoassay using beads coated with products of HIV gene].
    Hattori T; Koito A; Sutoh H; Takatsuki K
    Rinsho Byori; 1987 May; 35(5):577-81. PubMed ID: 3302414
    [No Abstract]   [Full Text] [Related]  

  • 16. Safeguarding the blood supply by providing opportunities for anonymous HIV testing.
    Snyder AJ; Vergeront JM
    N Engl J Med; 1988 Aug; 319(6):374-5. PubMed ID: 3164832
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of routine HTLV-III antibody testing on public health.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(5):1-9. PubMed ID: 3537748
    [No Abstract]   [Full Text] [Related]  

  • 18. [Donors with positive antibodies against HIV virus in Red Cross blood banks].
    Franco E; Picazo J; Mazón C; Antich JL; Lafulla C; Ribó E; Contreras E
    Sangre (Barc); 1986; 31(6):775-6. PubMed ID: 3470958
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of HTLV-III antibody in American blood donors.
    Schorr JB; Berkowitz A; Cumming PD; Katz AJ; Sandler SG
    N Engl J Med; 1985 Aug; 313(6):384-5. PubMed ID: 3859750
    [No Abstract]   [Full Text] [Related]  

  • 20. [Survey of antiviral antibodies against human immunodeficiency virus in a population of 11,174 blood donors].
    Muñiz Díaz E; Madoz P; Lluch A
    Med Clin (Barc); 1987 Nov; 89(16):709-10. PubMed ID: 3480407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.